Endocrinology

Regarding the true incidence of obesity in school-aged children of the Moscow Region

P. 698-701

Authors: T.A. Bokova E.E. Gribova D.A. Kartashova A.S. Bevz

0

1433

Serum levels of 25(OH)D and visfatin as markers of NAFLD in obesity and overweight

P. 702-709

Authors: F.Kh. Dzgoeva O.A. Radaeva K.A. Krasnoglazova A.A. Arkhipkin E.K. Mamieva S.A. Smetanina

0

1382

Metabolic and cardioprotective effects of ipragliflozin in patients with type 2 diabetes mellitus and arterial hypertension

P. 710-719

Authors: I.V. Druk S.S. Safronova O.I. Kanunnikova U.A. Bykova Т.A. Ushakova M.V. Novitskaya

0

1170

Individualized treatment tactics for postmenopausal osteoporosis therapy: analysis of clinical experience with zoledronic acid

P. 720-725

Authors: E.S. Zhugrova V.I. Mazurov I.B. Belyaeva D.A. Shimansky V.E. Gumerova

0

1518

Changes in body composition: the role of interleukins and adipokines (literature review)

P. 726-734

Authors: R.R. Gizatullina E.M. Gafuryanova D.G. Zhamankulova A.V. Tyurin

0

1617

Disordered carbohydrate metabolism and its impact on hemostasis: from hypercoagulation to cardiovascular complications

P. 735-742

Authors: V.V. Salukhov L.A. Asadova N.A. Varavin

0

1963

Type 2 diabetes mellitus and NAFLD: the protective effects of glucose-lowering drugs

P. 743-748

Authors: Yu.A. Dolgikh S.V. Bulgakova L.A. Sharonova O.V. Kosareva E.V. Treneva P.Ya. Merzlova D.P. Kurmaev

0

1761

Role of GLP-1 RA and GLP-1/GIP RA in comprehensive preconception preparation for women with obesity

P. 749-756

Authors: T.L. Karonova A.A. Nikulina A.V. Murasheva A.V. Tiselko A.T. Chernikova A.I. Shavinina N.A. Sukhotskaya

0

3691

Impact of dipeptidyl peptidase-4 inhibitors on bone tissue and fracture risk (literature review)

P. 758-764

Authors: T.L. Karonova N.V. Timkina O.S. Fuks A.S. Ametov

0

958

Disease experience in patients with pituitary neuroendocrine tumors

P. 765-769

Authors: Sh.A. Eganian P.V. Goncharenko N.V. Grineva K.A. Iakovenko U.A. Tsoy

0

826